S 2952 United States Senate · 117th Congress

FDA Modernization Act of 2021

Summary
FDA Modernization Act of 2021 This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, computer modeling, and other human biology-based test methods.
Bill status in committee 1 of 4 stages cleared
Introduction
Oct 2021
Committee Review
Floor Vote
President
Introduced Oct 7, 2021 Last action Oct 7, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Oct 7, 2021
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Oct 7, 2021
Introduced
Introduced in Senate
upper
1 primary · 15 co-sponsors

Sponsors